ArticlePharmacology research & perspectives2023

A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitor.

Terri L Morton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.